DGAP-News

RHÖN-KLINIKUM AG: Interim Report for the First Quarter of 2016: financial year starts well - strategic focus on digitalisation and promoting innovation

DGAP-News: RHÖN-KLINIKUM AG / Key word(s): Quarter Results/Quarter Results
RHÖN-KLINIKUM AG: Interim Report for the First Quarter of 2016: financial
year starts well - strategic focus on digitalisation and promoting
innovation

06.05.2016 / 07:00
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Corporate News

Interim Report for the First Quarter of 2016: financial year starts well -
strategic focus on digitalisation and promoting innovation

- 205,578 patients treated

- Revenues stand at EUR 291.5 million

- EBITDA of approx. EUR 68 million includes positive one-off effect of
roughly EUR 36 million

- Outlook for 2016: Revenues between EUR 1.17 billion and EUR 1.20
billion,EBITDA between EUR 155 million and EUR 165 million

Bad Neustadt / Saale, 6th May 2016

In the first quarter of the current financial year over 200,000 (205,578 to
be precise) patients were treated in the hospitals of RHÖN-KLINIKUM AG.
Revenues for the same period amounted to EUR 291.5 million with earnings
before interest, taxes, depreciation and amortisation (EBITDA) standing at
EUR 67.9 million. This also includes a positive special influence in the
amount of EUR 36.4 million after dissolving provisions for warranty claims
from the sale of a total of 43 facilities to Helios/Fresenius which was
completed in 2014. The current financial figures are therefore not directly
comparable with those of previous years due to these ongoing effects on the
balance sheet.

Annual General Meeting on 8th June 2016

The Board of Management and Supervisory Board shall propose to this year's
ordinary Annual General Meeting on 8th June 2016 in Frankfurt/Main the
distribution of a dividend in the amount of EUR 0.80 per non-par share.
This results in a dividend amount of almost EUR 54 million based on the
current number of roughly 67 million shares. RHÖN-KLINIKUM AG also intends
the shareholders to be able to participate extensively in the future
success of the Company by means of dividend payout ratios which are above
60 %, thereby allowing the Company to remain in M-Dax with an attractive
dividend value.

Outlook

For financial year 2016 we expect revenues of EUR 1.17 billion to EUR 1.20
billion and earnings before interest, taxes, depreciation and amortisation
(EBITDA) of between EUR 155 million and EUR 165 million. Positive and
negative one-off effects, the size of which will be a low to medium
two-digit million figure, will continue to influence the corporate results
during this financial year as well and will partially cancel each other